Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Jeffrey V. Poulton Insider Profile
4 Followers
Jeffrey V. Poulton, Director at Q32 Bio, holds ― shares in Q32 Bio (Ticker: QTTB), holds 30.70K shares in Alnylam Pharma (Ticker: ALNY), holds ― shares in CervoMed (Ticker: CRVO). Most recently, Jeffrey V. Poulton ― shares of Q32 Bio on ― for an estimated value of ―.
Profitable Transactions
3 out of 5 Profitable Transactions
Average Return
-12.50%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Jeffrey V. Poulton holds in companies
Most Profitable Insider Trade
The most profitable trade made by Jeffrey V. Poulton
Jeffrey V. Poulton's Trading History
Q32 Bio
―
Director
―
―
Alnylam Pharma
Nov 27, 2024
EVP & CFO
Uninformative Buy
―
$7.31M
CervoMed
―
Director
―
―
List of latest transactions for each holding click on a transaction to see Jeffrey V. Poulton's performance on stock
You May Also Like
Jeffrey V. Poulton insider profile FAQ
What is the percentage of profitable transactions made by Jeffrey V. Poulton?
The percentage of profitable transactions made by Jeffrey V. Poulton is 60%.
What is the average return per transaction made by Jeffrey V. Poulton?
The average return per transaction made by Jeffrey V. Poulton is -12.50%.
What stocks does Jeffrey V. Poulton hold?
Jeffrey V. Poulton holds: QTTB, ALNY, CRVO stocks.
What was Jeffrey V. Poulton’s latest transaction?
Jeffrey V. Poulton latest transaction was an Uninformative Buy of ―.
What was Jeffrey V. Poulton's most profitable transaction?
Jeffrey V. Poulton’s most profitable transaction was an Informative Sell of ALNY stock on April 28, 2023. The return on the trade was 28.00%.
What is Jeffrey V. Poulton's role in Q32 Bio?
Jeffrey V. Poulton's role in Q32 Bio is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.